Video

Lisa Rathman, MSN: The Benefits of Subcutaneous Furosemide in Nursing Homes

Author(s):

Lisa Rathman, MSN, of Lancaster General Hospital, discusses the benefits of subcutaneous furosemide in nursing homes and facilities outside the hospital.

Lisa Rathman, MSN: The benefit of subcutaneous lacix (furosemide) is an opportunity to be able to diuresis patients that are mildly symptomatic with congestion, or mild-to-moderately symptomatic but hemodynamically stable, in the outpatient setting, in the home, in the skilled nursing facility, and not have to bring them into the hospital or give them IV diuretics in the clinic. Giving IV diuretics has some issues as far as you have to have a line, and if you give the patient IV diuretics in the clinic, in the time frame for them to drive from point A to point B can be problematic. This gives an opportunity to give the patient diuresis but in their home setting.

In my current hospital situation, we partner with 10 facilities and we are starting to do IV diuretics in the nursing homes, but before that, it was impossible to get IV diuretics. It's getting better because we're partnering and they're seeing the benefits of trying to keep patients in the skilled facility, not go back to the hospital at a rapid pace. So they bought into it, but it's a lot of work for them. They don't have the staff. I think that, for them, it would be so much easier to be able to do a subcutaneous injection rather than doing IV, and I think that's absolutely clear. The other place I think would be very helpful is personal care homes because they definitely do not have nursing staff to do that. They may just have medical assistants who don't have the ability to give any kind of IV diuretics.

Related Videos
Ahmad Masri, MD, MS: Reaching New Milestones in Cardiovascular Gene Therapy Development
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
© 2024 MJH Life Sciences

All rights reserved.